Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Multisystem Inflammatory Syndrome Associated with COVID-19 Anti-thrombosis Guideline of Care for Children by Action

Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium - eClinicalMedicine

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Research and Practice in Thrombosis and Haemostasis

Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database

Frontiers Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review

Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view

Frontiers Therapeutic Strategies for COVID-19 Lung Disease in Children

Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection

A guide to immunotherapy for COVID-19

IJMS, Free Full-Text

Frontiers Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland